- Current report filing (8-K)
December 28 2009 - 6:06AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of
report (Date of earliest event reported): December 1, 2009
CHINA
POLYPEPTIDE
GROUP,
INC.
(Exact
Name of Registrant as Specified in its Charter)
Delaware
|
333-151148
|
20-8731646
|
(State
or Other Jurisdiction
|
(Commission
File Number)
|
(IRS
Employer
|
of
Incorporation)
|
|
Identification
No.)
|
No. 11
Jiangda Road
Jianghan
Economical Development Zone
430023
Wuhan, P.R. China
|
(Address
of Principal Executive Offices)
|
Registrant's
telephone number, including area code: 86 27 835 183 96
Hamptons Extreme,
Inc.
(Former
name or former address, if changed since last report.)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (
see
General
Instruction A.2. below):
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
5.
0
3
.
Amendments to Articles of
Incorporation or Bylaws; Change in Fiscal Year.
On
December 1, 2009, Hamptons Extreme, Inc. (the “
Company
”)
filed a Certificate of Amendment with the Secretary of State of Delaware in
order to change the Company’s name to China Polypeptide Group, Inc. to more
accurately reflect its current business and to implement a forward split of the
Company’s common stock on the basis of 8 shares for every 1 share issued and
outstanding. Neither the total number of authorized shares, nor the
par value of the shares were changed by this action. The amendments
were approved by written consent of the Company’s board of directors and by
written consent of a majority of the Company’s shareholders effective on
December 1, 2009.
A copy of
the Certificate of Amendment is attached hereto as Exhibit 99.1
In
connection with the foregoing amendments, the Company submitted the required
information to FINRA in order to obtain a new trading symbol for its common
stock on the Over-the-Counter Bulletin Board. Effective as of the
opening of business on December 24, 2009, the Company’s Over-the-Counter
Bulletin Board trading symbol will be CHPN. The Company’s prior OTCBB
symbol was HMEX.
Item
9.01. Financial Statement and Exhibits
(d)
Financial Statements and Exhibits
Exhibit No.
|
|
Description
|
|
|
|
99.1
|
|
Certificate
of Amendment
|
SIGNATURES
Pursuant to the requirements of Section
12 of the Securities Exchange Act of 1934, the registrant has duly caused this
report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
CHINA
POLYPEPTIDE GROUP, INC.
|
|
|
Date:
December 23, 2009
|
|
|
/s/ Dongliang Chen
|
|
Name:
Dongliang Chen
|
|
Title:
Chairman and Chief Executive
Officer
|